Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Mpower"

503 News Found

FDA nod to Johnson & Johnson’s oral psoriasis therapy 'ICOTYDE'
News | March 25, 2026

FDA nod to Johnson & Johnson’s oral psoriasis therapy 'ICOTYDE'

New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis


Sakura Finetek and Hamamatsu forge alliance to transform digital pathology workflow
Medical Device | March 21, 2026

Sakura Finetek and Hamamatsu forge alliance to transform digital pathology workflow

Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process


Roche breaks lab barriers as FDA clears mass spec tests for wider use
News | March 20, 2026

Roche breaks lab barriers as FDA clears mass spec tests for wider use

The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio


Zydus, Lupin join forces to expand access to semaglutide in India
News | March 18, 2026

Zydus, Lupin join forces to expand access to semaglutide in India

The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus


Allergan Aesthetics unveils ‘Skin Quality Index’ to close gap between patients & doctors
Healthcare | March 17, 2026

Allergan Aesthetics unveils ‘Skin Quality Index’ to close gap between patients & doctors

The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health


WHO Foundation and Novo Nordisk join hands to fight childhood obesity in India
News | March 14, 2026

WHO Foundation and Novo Nordisk join hands to fight childhood obesity in India

The initiative will focus on creating healthier early-life environments, promoting physical activity, identifying risks early, and strengthening preparedness within primary health care systems


India tackles rare diseases head-on at landmark summit in New Delhi
News | March 12, 2026

India tackles rare diseases head-on at landmark summit in New Delhi

Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration


Alcon launches Hydrus Microstent in India to transform glaucoma care
News | March 11, 2026

Alcon launches Hydrus Microstent in India to transform glaucoma care

The Hydrus Microstent stands out as the first and only MIGS device backed by five-year clinical outcomes


FDA nod to YUVIWEL, first once-weekly treatment for kids with achondroplasia
News | March 03, 2026

FDA nod to YUVIWEL, first once-weekly treatment for kids with achondroplasia

Achondroplasia, a rare genetic disorder, causes skeletal dysplasia and often increases the risk of muscular, neurological, and cardiorespiratory complications